Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-6-26
|
pubmed:abstractText |
The major histocompatibility complex (MHC) gene, HLA-B27 is strongly associated with auto-immune uveitis and spondyloarthropathies in humans. Experimental mouse models of autoimmune uveitis involve systemic immunization with the retinal autoantigen interphotoreceptor retinoid binding protein (IRBP). To assess possible roles of HLA-B27 in autoimmune uveitis, as well as to investigate a possible new animal model of human uveitis, inbred strains of C57BL/6 and C57BL/6 possessing the human HLA-B27 or HLA-A2 transgene were immunized with IRBP emulsified in complete Freund's adjuvant (CFA). Dilated eye examinations were performed to assess the timing and clinical course of any ensuing uveitis. Mice were sacrificed 3 to 4 weeks postinjection and the eyes submitted for histopathologic analysis. CFA alone did not produce any clinical uveitis. Fifty percent of eyes from the background C57BL/6 strain developed uveitis as early as 10 days postinjection. Of the eyes demonstrating uveitis, an average clinical score of 2.5 was present. Pathologically, a moderate scleritis and anterior uveitis was present. Fifty percent of A2 transgenic eyes developed uveitis as early as 14 days postinjection with an average clinical score of 2.0. Pathologically, a mild vitritis was present. Uveitis developed in only 20% of B27 transgenic mice and reached a peak on day 28. The average EAU score in diseased animals was 4.5. A dense retinitis and panuveitis was associated with severe vitritis. We conclude that the presence of the B27 gene is associated with a decreased incidence and slower rate of onset of EAU following immunization with IRBP; however, EAU may be more severe in the HLA-B27 expressing animals who do develop disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Eye Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-A2 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-B27 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Retinol-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/interstitial retinol-binding protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0198-8859
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
188-94
|
pubmed:dateRevised |
2007-7-27
|
pubmed:meshHeading |
pubmed-meshheading:9129978-Animals,
pubmed-meshheading:9129978-Autoimmune Diseases,
pubmed-meshheading:9129978-Eye Proteins,
pubmed-meshheading:9129978-Female,
pubmed-meshheading:9129978-HLA-A2 Antigen,
pubmed-meshheading:9129978-HLA-B27 Antigen,
pubmed-meshheading:9129978-Humans,
pubmed-meshheading:9129978-Injections, Subcutaneous,
pubmed-meshheading:9129978-Male,
pubmed-meshheading:9129978-Mice,
pubmed-meshheading:9129978-Mice, Inbred C57BL,
pubmed-meshheading:9129978-Mice, Transgenic,
pubmed-meshheading:9129978-Retinol-Binding Proteins,
pubmed-meshheading:9129978-Transgenes,
pubmed-meshheading:9129978-Uveitis
|
pubmed:year |
1997
|
pubmed:articleTitle |
Experimental autoimmune uveitis in HLA-B27 transgenic mice.
|
pubmed:affiliation |
University of Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|